PMID: 18855611

Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, Lai X, Wang JC, Li CG, Tian M, Duan W
Clinical pharmacogenetics and potential application in personalized medicine.
Curr Drug Metab. 2008 Oct;9(8):738-84., [PubMed]
Sentences
No. Mutations Sentence Comment
487 ABCB1 p.Asn21Asp
X
ABCB1 p.Asn21Asp 18855611:487:44
status: NEW
view ABCB1 p.Asn21Asp details
ABCB1 p.Phe103Leu
X
ABCB1 p.Phe103Leu 18855611:487:93
status: NEW
view ABCB1 p.Phe103Leu details
Exon 2 contains a polymorphism that changes Asn21 to Asp, and the mutation at exon 5 changes Phe103 to Leu. Login to comment
489 ABCB1 p.Ser400Asn
X
ABCB1 p.Ser400Asn 18855611:489:62
status: NEW
view ABCB1 p.Ser400Asn details
The 1199G>A polymorphism is located at exon 11, which changes Ser400 to Asn. Login to comment
532 ABCB1 p.Gly185Val
X
ABCB1 p.Gly185Val 18855611:532:280
status: NEW
view ABCB1 p.Gly185Val details
ABCB1 p.Asn183Ser
X
ABCB1 p.Asn183Ser 18855611:532:257
status: NEW
view ABCB1 p.Asn183Ser details
ABCB1 p.Ser400Asn
X
ABCB1 p.Ser400Asn 18855611:532:328
status: NEW
view ABCB1 p.Ser400Asn details
ABCB1 p.Asn21Asp
X
ABCB1 p.Asn21Asp 18855611:532:96
status: NEW
view ABCB1 p.Asn21Asp details
ABCB1 p.Gln1107Pro
X
ABCB1 p.Gln1107Pro 18855611:532:831
status: NEW
view ABCB1 p.Gln1107Pro details
ABCB1 p.Ser893Ala
X
ABCB1 p.Ser893Ala 18855611:532:676
status: NEW
view ABCB1 p.Ser893Ala details
ABCB1 p.Ser1141Thr
X
ABCB1 p.Ser1141Thr 18855611:532:908
status: NEW
view ABCB1 p.Ser1141Thr details
ABCB1 p.Pro1051Ala
X
ABCB1 p.Pro1051Ala 18855611:532:728
status: NEW
view ABCB1 p.Pro1051Ala details
ABCB1 p.Arg669Cys
X
ABCB1 p.Arg669Cys 18855611:532:502
status: NEW
view ABCB1 p.Arg669Cys details
ABCB1 p.Thr1256Lys
X
ABCB1 p.Thr1256Lys 18855611:532:1011
status: NEW
view ABCB1 p.Thr1256Lys details
ABCB1 p.Leu662Arg
X
ABCB1 p.Leu662Arg 18855611:532:477
status: NEW
view ABCB1 p.Leu662Arg details
ABCB1 p.Val1251Ile
X
ABCB1 p.Val1251Ile 18855611:532:986
status: NEW
view ABCB1 p.Val1251Ile details
ABCB1 p.Ile849Met
X
ABCB1 p.Ile849Met 18855611:532:650
status: NEW
view ABCB1 p.Ile849Met details
ABCB1 p.Met89Thr
X
ABCB1 p.Met89Thr 18855611:532:186
status: NEW
view ABCB1 p.Met89Thr details
ABCB1 p.Trp1108Arg
X
ABCB1 p.Trp1108Arg 18855611:532:857
status: NEW
view ABCB1 p.Trp1108Arg details
ABCB1 p.Ile261Val
X
ABCB1 p.Ile261Val 18855611:532:304
status: NEW
view ABCB1 p.Ile261Val details
ABCB1 p.Asn44Ser
X
ABCB1 p.Asn44Ser 18855611:532:118
status: NEW
view ABCB1 p.Asn44Ser details
ABCB1 p.Ile829Val
X
ABCB1 p.Ile829Val 18855611:532:600
status: NEW
view ABCB1 p.Ile829Val details
ABCB1 p.Gly1063Ala
X
ABCB1 p.Gly1063Ala 18855611:532:753
status: NEW
view ABCB1 p.Gly1063Ala details
ABCB1 p.Ala80Glu
X
ABCB1 p.Ala80Glu 18855611:532:163
status: NEW
view ABCB1 p.Ala80Glu details
ABCB1 p.Ala599Thr
X
ABCB1 p.Ala599Thr 18855611:532:427
status: NEW
view ABCB1 p.Ala599Thr details
ABCB1 p.Val801Met
X
ABCB1 p.Val801Met 18855611:532:576
status: NEW
view ABCB1 p.Val801Met details
ABCB1 p.Phe17Leu
X
ABCB1 p.Phe17Leu 18855611:532:63
status: NEW
view ABCB1 p.Phe17Leu details
ABCB1 p.Arg593His
X
ABCB1 p.Arg593His 18855611:532:403
status: NEW
view ABCB1 p.Arg593His details
ABCB1 p.Arg593Cys
X
ABCB1 p.Arg593Cys 18855611:532:378
status: NEW
view ABCB1 p.Arg593Cys details
ABCB1 p.Asp613Tyr
X
ABCB1 p.Asp613Tyr 18855611:532:452
status: NEW
view ABCB1 p.Asp613Tyr details
ABCB1 p.Ser992Asn
X
ABCB1 p.Ser992Asn 18855611:532:703
status: NEW
view ABCB1 p.Ser992Asn details
ABCB1 p.Ile60Leu
X
ABCB1 p.Ile60Leu 18855611:532:141
status: NEW
view ABCB1 p.Ile60Leu details
ABCB1 p.Ser1137Ile
X
ABCB1 p.Ser1137Ile 18855611:532:883
status: NEW
view ABCB1 p.Ser1137Ile details
ABCB1 p.Ile836Val
X
ABCB1 p.Ile836Val 18855611:532:625
status: NEW
view ABCB1 p.Ile836Val details
ABCB1 p.Asp800Asn
X
ABCB1 p.Asp800Asn 18855611:532:552
status: NEW
view ABCB1 p.Asp800Asn details
ABCB1 p.Lys1168Glu
X
ABCB1 p.Lys1168Glu 18855611:532:934
status: NEW
view ABCB1 p.Lys1168Glu details
ABCB1 p.Ile144Thr
X
ABCB1 p.Ile144Thr 18855611:532:209
status: NEW
view ABCB1 p.Ile144Thr details
ABCB1 p.Asp1088Asn
X
ABCB1 p.Asp1088Asn 18855611:532:779
status: NEW
view ABCB1 p.Asp1088Asn details
ABCB1 p.Val168Ile
X
ABCB1 p.Val168Ile 18855611:532:233
status: NEW
view ABCB1 p.Val168Ile details
ABCB1 p.Lys1099Glu
X
ABCB1 p.Lys1099Glu 18855611:532:805
status: NEW
view ABCB1 p.Lys1099Glu details
ABCB1 p.Glu1223Asp
X
ABCB1 p.Glu1223Asp 18855611:532:960
status: NEW
view ABCB1 p.Glu1223Asp details
ABCB1 p.Ile736Lys
X
ABCB1 p.Ile736Lys 18855611:532:527
status: NEW
view ABCB1 p.Ile736Lys details
ABCB1 p.Glu566Lys
X
ABCB1 p.Glu566Lys 18855611:532:353
status: NEW
view ABCB1 p.Glu566Lys details
Nucleotide change rs number Amino acid change 49T>C rs28381804 F17L 61A>G rs61615398; rs9282564 N21D 131A>G rs1202183 N44S 178A>C rs41315618 I60L 239C>A rs9282565 A80E 266T>C Rs35810889 M89T 431T>C rs61607171 I144T 502G>A rs61122623 V168I 548A>G rs60419673 N183S 554G>T rs1128501 G185V 781A>G rs36008564 I261V 1199G>A rs2229109 S400N 1696G>A rs28381902 E566K 1777C>T rs28381914 R593C 1778G>A rs56107566 R593H 1795G>A rs2235036 A599T 1837G>T rs57001392 D613Y 1985T>G rs61762047 L662R 2005C>T rs35023033 R669C 2207A>T rs41316450 I736K 2398G>A rs41305517 D800N 2401G>A rs2235039 V801M 2485A>G rs2032581 I829V 2506A>G rs28381967 I836V 2547A>G rs36105130 I849M 2677T>A/G rs2032582 S893A/T 2975G>A rs56849127 S992N 3151C>G rs28401798 P1051A 3188G>C rs2707944 G1063A 3262G>A rs57521326 D1088N 3295A>G rs41309225 K1099E 3320A>C rs55852620 Q1107P 3322T>C rs35730308 W1108R 3410G>T rs41309228 S1137I 3421T>A rs2229107 S1141T 3502A>G rs59241388 K1168E 3669A>T rs41309231 E1223D 3751G>A rs28364274 V1251I 3767C>A r35721439 T1256K Data are from NCBI dbSNP (access date: 2 August 2008). Login to comment
614 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 18855611:614:178
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 18855611:614:197
status: VERIFIED
view ABCG2 p.Arg482Gly details
It was discovered that the first cloned BCRP cDNA [265] encoded a mutant BCRP that differs from the wild-type BCRP at Arg482 (R482), which was substituted with either threonine (R482T) or glycine (R482G) [269]. Login to comment
618 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:618:55
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:618:49
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 18855611:618:69
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 18855611:618:62
status: VERIFIED
view ABCG2 p.Gln166Glu details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 18855611:618:76
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 18855611:618:83
status: VERIFIED
view ABCG2 p.Ser248Pro details
ABCG2 p.Phe571Ile
X
ABCG2 p.Phe571Ile 18855611:618:111
status: VERIFIED
view ABCG2 p.Phe571Ile details
ABCG2 p.Asp296His
X
ABCG2 p.Asp296His 18855611:618:90
status: VERIFIED
view ABCG2 p.Asp296His details
ABCG2 p.Ala528Thr
X
ABCG2 p.Ala528Thr 18855611:618:104
status: VERIFIED
view ABCG2 p.Ala528Thr details
ABCG2 p.Leu525Arg
X
ABCG2 p.Leu525Arg 18855611:618:97
status: VERIFIED
view ABCG2 p.Leu525Arg details
Only a small portion of them are non-synonymous (V12M, Q141K, Q166E, I206L, F208S, S248P, D296H, L525R, A528T, F571I, and Y590N) and there is one frameshift (1515delC) mutation observed in the coding region of ABCG2. Login to comment
619 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:619:53
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:619:35
status: VERIFIED
view ABCG2 p.Val12Met details
Among the above variations, 34G>A (V12M) AND 421C>A (Q141K) have been testified to be polymorphic in numerous populations [267, 271]. Login to comment
620 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:620:4
status: VERIFIED
view ABCG2 p.Val12Met details
The V12M polymorphism located in exon 2 influenced the N-terminal intracellular region of the protein. Login to comment
622 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:622:4
status: VERIFIED
view ABCG2 p.Val12Met details
The V12M polymorphism was discovered in all ethnic groups tested, found with the highest allele frequency in Mexican-Indians (90%, but only 10 individuals were tested), while only 2% in a Swedish population [272]. Login to comment
623 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:623:146
status: VERIFIED
view ABCG2 p.Val12Met details
Upon the combination of several population studies, a consistent and significant difference can be seen between the overall allele frequencies of V12M in Caucasian, African American and Japanese populations [271]. Login to comment
624 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:624:4
status: VERIFIED
view ABCG2 p.Gln141Lys details
The Q141K polymorphism located in exon 5 leads to the replacement of the negatively charged glutamic acid residue with a positively charged lysine residue. Login to comment
626 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:626:4
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:626:78
status: VERIFIED
view ABCG2 p.Gln141Lys details
The Q141K variant was detected in all ethnic groups tested; it was found that Q141K occurs frequently in Asian populations ranging from (~30-60%) and relatively low allele frequency in Caucasians and African American subjects (~5-10%) [273]. Login to comment
627 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:627:150
status: VERIFIED
view ABCG2 p.Gln141Lys details
For example, 60% are heterozygous for Q141 K in a Chinese population; 39-50% heterozygous for a Japanese population and 7% homozygous for the variant Q141K. Login to comment
628 ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 18855611:628:31
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 18855611:628:48
status: VERIFIED
view ABCG2 p.Asp620Asn details
Several other variants such as I206L, N520Y and D620N are much less frequent with allele frequencies of ~1%. Login to comment
630 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:630:54
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:630:110
status: VERIFIED
view ABCG2 p.Val12Met details
Studies have discovered that the expression levels of Q141K ABCG2 protein is lower than the wild-type, or the V12M variant when expressed in PA317 or HEK-293 cells [273]. Login to comment
631 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:631:36
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:631:124
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:631:115
status: VERIFIED
view ABCG2 p.Val12Met details
It was also found that a portion of Q141K remained intracellular despite having a low level of expression, as both V12M and Q141K BCRP could reach the plasma membrane in the HEK-293 cells [273]. Login to comment
632 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:632:84
status: VERIFIED
view ABCG2 p.Gln141Lys details
Other reports quoted that there is a 30-40% reduction in expression of cell surface Q141K variant, despite having a similar mRNA level compared to the wild-type. Login to comment
633 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:633:31
status: VERIFIED
view ABCG2 p.Gln141Lys details
Individuals homozygous for the Q141K variant had significantly lower expression levels of BCRP in the placenta while the heterozygous samples displayed an intermediate expression level [274]. Login to comment
635 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:635:164
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:635:85
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 is expressed in polarized LLC-PKI cells, and a study has demonstrated that the V12M variant has an intracellular localization whereas the wild-type ABCG2 and Q141K show mainly apical staining [275]. Login to comment
636 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:636:45
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 18855611:636:65
status: VERIFIED
view ABCG2 p.Gln166Glu details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 18855611:636:82
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Ala149Pro
X
ABCG2 p.Ala149Pro 18855611:636:51
status: VERIFIED
view ABCG2 p.Ala149Pro details
ABCG2 p.Pro269Ser
X
ABCG2 p.Pro269Ser 18855611:636:72
status: VERIFIED
view ABCG2 p.Pro269Ser details
ABCG2 p.Arg163Lys
X
ABCG2 p.Arg163Lys 18855611:636:58
status: VERIFIED
view ABCG2 p.Arg163Lys details
The localization of other variants including V12M, A149P, R163K, Q166E, P269S and S441N was also examined. Login to comment
637 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:637:38
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:637:29
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 18855611:637:86
status: VERIFIED
view ABCG2 p.Ser441Asn details
All polymorphisms, including V12M and Q141K, had an apical localization, and only the S441N variant displayed an intracellular staining [275]. Login to comment
639 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:639:90
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:639:154
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:639:145
status: VERIFIED
view ABCG2 p.Val12Met details
Further studies are required to clarify the mechanism of a reduced protein expression for Q141K, and the change of cellular localization for the V12M and Q141K variants found under specific conditions. Login to comment
641 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:641:99
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:641:91
status: VERIFIED
view ABCG2 p.Val12Met details
There was a 10-fold decrease in drug resistance compared with the wild-type ABCG2 when the V12M or Q141K-transfected LLC-PKI cells were challenged by mitoxantrone or topotecan [275]. Login to comment
642 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:642:65
status: VERIFIED
view ABCG2 p.Gln141Lys details
In contrast, when compared to wild-type ABCG2-transfected cells, Q141K variant alone had a fairly lower level resistance against mitoxantrone, topotecan or SN-38. Login to comment
644 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:644:45
status: VERIFIED
view ABCG2 p.Gln141Lys details
In the ATP-binding cassette region of ABCG2, Q141K is between the Walker A and the signature motifs; hence variant ATPase activity alteration is possible. Login to comment
645 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:645:104
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:645:95
status: VERIFIED
view ABCG2 p.Val12Met details
Experiments were undertaken to observe between the vanadate-sensitive ATPase activity of ABCG2 V12M and Q141K variants, using Sf9 (Spodoptera frugiperda) cell membranes [276]. Login to comment
646 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 18855611:646:85
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:646:76
status: VERIFIED
view ABCG2 p.Val12Met details
There was a 1.3 and 1.8-fold lower basal ATPase activity, respectively, for V12M and Q141K compared to wild-type [276]. Login to comment
647 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 18855611:647:23
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 18855611:647:33
status: VERIFIED
view ABCG2 p.Asp620Asn details
On the other hand, the V12M (and D620N) ABCG2 displayed a comparable ATPase activity as the wild-type protein. Login to comment